Mahsa Shabani in Science about the re-use of newborn screening samples for research
Read the interview with Mahsa Shabani in Science Magazine about the re-use of newborn screening samples for research.

The recent controversy in Denmark surrounding the (re-)use of newborn screening samples for broad research purposes has sparked serious ethical and legal questions. The case highlights gaps in current safeguards and challenges the public’s trust in health systems.
Law for Health and Life’s Mahsa Shabani is interviewed about the controversy in Science Magazine, highlighting that we must be extremely cautious when managing the secondary use of data collected through public health screening programs. Trust is fundamental, people need to be confident not only in the purpose of screening, but also in how their data and samples may be used in the future.

New publication by Katrina Perehudoff on global impact of EU pharmaceutical legislation
Katrina Perehudoff from Law for Health and Life, has published a new article in BMJ Global Health examining the global implications of the European Union’s proposed pharmaceutical legislation reforms.
Regulatory Gaps in AI-Powered Medical Chatbots: Insights from Hannah van Kolfschooten
In a technical commentary, Hannah van Kolfschooten builds on the insights of Nehme et al. by addressing the growing reliance on general-purpose AI, like ChatGPT, in medical contexts.